DWA
MEDP icon

Dorsey Wright & Associates’s Medpace MEDP Stock Holding History

Dorsey Wright & Associates’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,140
Closed -$13.5M – 167
2026
Q1 		$13.5M Buy
28,140
+5,720
+26% +$2.93M 1.67% 17
2025
Q4 		$12.6M Buy
22,420
+12,535
+127% +$7.12M 2.72% 6
2025
Q3 		$5.08M Buy
+9,885
New +$4.32M 1.14% 27
2024
Q3 		– Sell
-9,730
Closed -$4.01M – 135
2024
Q2 		$4.01M Sell
9,730
-8
-0.1% -$3.17K 1.04% 27
2024
Q1 		$3.94M Buy
9,738
+136
+1% +$47.8K 1.03% 28
2023
Q4 		$2.94M Sell
9,602
-261
-3% -$70.5K 0.89% 48
2023
Q3 		$2.39M Buy
+9,863
New +$2.52M 0.74% 68

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Dorsey Wright & Associates's MEDP Position: Q2 2026 in Review

Dorsey Wright & Associates sold out of Medpace (MEDP) in Q2 2026, closing a stake of 28,140 shares — an estimated $13.5M sold.

Dorsey Wright & Associates first reported a position in MEDP in Q3 2023 and held it in 7 quarters. The position peaked at $13.5M in Q1 2026. 547 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Dorsey Wright & Associates reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Dorsey Wright & Associates sold 28,140 Medpace shares in Q2 2026, an estimated $13.5M.
  • Dorsey Wright & Associates first reported a position in Medpace in Q3 2023 and held it in 7 quarters.
  • Dorsey Wright & Associates's Medpace position peaked at $13.5M in Q1 2026.
  • 547 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.